Lindi Mathebula

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Infectious Diseases

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Lindi Mathebula, Thobile Malinga, Mammekwa Mokgoro, Duduzile Ndwandwe, Charles S Wiysonge, Glenda Gray
Cholera vaccine clinical trials: A cross-sectional analysis of clinical trials registries. Human vaccines & immunotherapeutics 19 (2) (2023)
Duduzile Edith Ndwandwe, Sinazo Runeyi, Elizabeth Pienaar, Lindi Mathebula, Ameer Hohlfeld, Charles Shey Wiysonge
Practices and trends in clinical trial registration in the Pan African Clinical Trials Registry (PACTR): a descriptive analysis of registration data. BMJ open 12 (1) (2022)
Lindi Mathebula, Lovemore Mapahla, Dilyara Nurkhametova, Liliya Eugenevna Ziganshina, Mikateko Mazinu, Esme Jordan, Duduzile Edith Ndwandwe, Tamara Kredo
Planned, ongoing and completed tuberculosis treatment trials in Brazil, Russia, India, China and South Africa: a 2019 cross-sectional descriptive analysis. BMJ open 12 (6) (2022)
Lindi Mathebula, Sinazo Runeyi, Charles Wiysonge, Duduzile Ndwandwe
Clinical trial registration during COVID-19 and beyond in the African context: what have we learned? Trials 23 (1) (2022)
Chinwe-Juliana Iwu Jaja, Ntombenhle J Ngcobo, Sara Cooper, Lindi Mathebula, Hlokoma Mangqalaza, Abongile Magwaca, Usuf Chikte, Charles Shey Wiysonge
Mobile reporting of vaccine stock-levels in primary health care facilities in the Eastern Cape Province of South Africa: perceptions and experiences of health care workers. Human vaccines & immunotherapeutics 16 (8) (2020)
Lindi Mathebula, Duduzile Edith Ndwandwe, Elizabeth Pienaar, Charles Shey Wiysonge
Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review. BMJ open 9 (7) (2019)
Duduzile Edith Ndwandwe, Kopano Rebaona Dube, Lindi Mathebula, Charles Shey Wiysonge
Description of vaccine clinical trials in Africa: a narrative review. Human vaccines & immunotherapeutics 16 (4) (2019)